Clinical Whitepaper
High-Level Disinfection for Ophthalmic Instruments and Eyedropper Bottles
A clinical whitepaper for ophthalmology, optometry, and ophthalmic surgery practices. Saniteyes™ UVC Disinfection System by Dropmate Inc.
≥6-log
Bacterial & fungal reduction
in 5 minutes
≥4-log
Viral reduction including Adenovirus Type 5
1,300+
PMMA cycles with zero structural degradation
The Disinfection Gap
The Disinfection Gap in Ophthalmic Practice
Tonometry is performed on virtually every patient in an ophthalmic clinic. The Goldmann applanation tonometer prism is classified as a semi-critical instrument requiring high-level disinfection (HLD) between patients. In practice, the dominant method — an IPA wipe — does not achieve HLD and has been directly linked to adenoviral transmission.
Instrument Degradation Under Chemical Protocols
PMMA tonometer prisms and diagnostic contact lenses are precision instruments with significant replacement costs. Repeated chemical disinfection causes measurable degradation in optical clarity and surface microstructure. In contrast, PMMA prisms subjected to 1,300+ Saniteyes™ cycles — simulating approximately five years of clinical use — showed no detected cracks, fissures, or biomechanical changes.
The Compliance Problem
Even theoretically adequate protocols are undermined by real-world variability. Chemical soaking requires preparation, timing, and rinsing steps that create friction in high-volume workflows. Staff turnover and inconsistent training produce a disinfection standard that exists on paper but not reliably in practice. Automated UVC disinfection removes operator technique as a variable — the same validated cycle on every use.
Eyedropper Bottles
The Eyedropper Bottle as an Overlooked Vector
Multi-dose eyedropper bottles are used in every ophthalmic clinic. These bottles are handled by staff, touched by multiple patients, and recapped repeatedly. Unlike tonometer tips, their disinfection is rarely considered, and most clinics have no established protocol for it.
Iatrogenic Ocular Dysbiosis
Low-grade, persistent inflammation caused by clinic-acquired microbial dysbiosis is frequently attributed to the patient's underlying condition or medication side effects. Contaminated instruments and shared bottles may represent an underrecognized driver of patient dissatisfaction, treatment failure, and poor online reviews related to redness, burning, or irritation following clinical visits.
Ocular Microbiome
The Ocular Surface Microbiome and Dysbiosis
The healthy ocular surface maintains a low-biomass microbiome critical for immunity, pathogen exclusion, and tear film stability. When contaminated instruments or drops repeatedly introduce non-commensal bacteria, the result is ocular dysbiosis — a shift toward pro-inflammatory profiles.
The Paradox of Prophylaxis
Standard perioperative antibiotic regimens reduce OSM diversity at 2 and 4 weeks post-operation, creating a vulnerability window. Using UVC-disinfected eyedropper bottles during this period ensures post-operative management does not inadvertently introduce pathogens onto an already-compromised ocular surface.
Saniteyes™ System
Saniteyes™ High-Level Disinfection System
The first FDA-registered, automated point-of-care UVC disinfection device purpose-built for semi-critical ophthalmic instruments. UVC induces pyrimidine dimer formation in microbial DNA/RNA — no chemical residue, no instrument damage, no opportunity for resistant strain selection.
Wavelength
254–280 nm (germicidal spectrum)
HLD Standard
≥6-log bacterial/fungal; ≥4-log viral
Cycle Time
5 min (standard) · 10 min (extended)
Capacity
3 independent bays
Dose Verification
Photochromic strips + electronic dosimeters
Compatible Instruments
Tonometer prisms, diagnostic lenses, laser lenses, eyedropper bottles, iCare probes
Regulatory Status
FDA-registered Class I medical device
Instrument Durability
>1,300 cycles, no degradation; LEDs rated 10,000+
Efficacy Against Clinically Relevant Pathogens
Staphylococcus aureus
Gram-positive
Blepharitis, keratitis, post-op infections
≥6-log
Pseudomonas aeruginosa
Gram-positive
Corneal ulcers; MDR strains in artificial tear outbreaks
≥6-log
Candida albicans
Fungus
Fungal keratitis, endophthalmitis
≥6-log
Mycobacterium terrae
Mycobacterium
HLD indicator organism; TB analog
≥6-log
Adenovirus Type 5
Non-enveloped virus
Primary agent of EKC; resistant to IPA
≥4-log
Bovine Coronavirus
Enveloped virus
Indicator for SARS-CoV-2 and respiratory viruses
≥4-log
Medication and Material Safety
UVC wavelengths cannot penetrate standard LDPE or glass ophthalmic bottles. The chamber orients the LED array to saturate the nozzle exterior while preventing irradiation from entering the bore. No rinsing required before patient use. No extractables or leachables introduced into the medication. Staff are never exposed to UV-C during normal operation via fully enclosed design with safety interlocks.
Implementation
Clinical Implementation
Tonometry & Diagnostic Instruments
Run a 5-minute cycle between every patient encounter. With one unit per exam lane and two prisms per lane (one in use, one cycling), throughput is not disrupted.
Stanford Health Care currently operates the system across 40 exam lanes, with no citations from The Joint Commission or DNV at institutions using the device.
Multi-Dose Clinic Bottles
Shared bottles including proparacaine, tetracaine, tropicamide, phenylephrine, and fluorescein represent the highest-risk vectors for cross-contamination.
Implementation requires placing the bottle in the device between encounters — a workflow step standardized at the slit lamp or exam lane.
Economic & Sustainability Impact
$3K–$10K
Annual savings on chemical
disinfectant consumables
100+ kg
Plastic waste reduction
per department annually
$50K–$150K
Total estimated annual savings
for larger practices
Recommendations
Recommendations for Clinical Practice
Immediate Protocol Updates
1
Replace alcohol-wipe protocols for tonometer tips with automated UVC disinfection between every patient to achieve validated HLD and eliminate EKC transmission risk.
2
Implement UVC disinfection for shared multi-dose clinic bottles (proparacaine, tropicamide, phenylephrine, fluorescein) between patient encounters.
3
Designate post-operative bottle management as an infection control priority. Use UVC-disinfected delivery systems during the 4-week post-surgical vulnerability window.
4
Document disinfection for semi-critical instruments using Saniteyes™ indicator strips and cycle logs to support OSHA and AAMI compliance.
Patient Communication
4
Counsel chronic drop users (glaucoma, DED) that contamination-driven dysbiosis may be contributing to persistent symptoms misattributed to medication side effects.
5
Provide clear bottle hygiene education including tip-to-lid contact risk, replacement intervals (30–60 days), and home disinfection options for high-risk patients.
6
Consider dysbiosis as a differential in patients with worsening redness, burning, or dry eye symptoms that correlate with prolonged use of a single multi-dose bottle.
References
1.
Shankar V, Shukla A, Ianchulev P, et al. Efficacy of an Automated Point-of-Care UVC Disinfection System for Reusable Ophthalmic Devices. Ophthalmology. 2026. doi:10.1016/j.ophtha.2025.12.032
2.
Kugadas A, Gadjeva M. Impact of Microbiome on Ocular Health. Ocul Surf. 2016;14(3):342-349.
3.
Dong Q, et al. Diversity of Bacteria at Healthy Human Conjunctiva. Invest Ophthalmol Vis Sci. 2011;52(8):5408.
4.
Tariq F, et al. The Ocular Surface Microbiome in Homeostasis and Dysbiosis. Microorganisms. 2025;13(9):1992.
5.
Dong X, et al. Composition and Diversity of Bacterial Community in Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci. 2019;60(14):4774.
6.
Ozkan J, Willcox MD. The Ocular Microbiome. Curr Eye Res. 2019;44(7):685-694.
7.
Okonkwo A, et al. Next-Generation Sequencing of the Ocular Surface Microbiome. Eye & Contact Lens. 2020;46(4):254-261.
8.
CDC: Outbreak of Extensively Drug-Resistant Pseudomonas aeruginosa Associated with Artificial Tears. archive.cdc.gov.
Pilot Saniteyes at Your Institution
We offer complimentary one-month pilots for academic medical centers, health systems, and high-volume practices.